Controversy About Management of Osteoarthritis with Disease-modifying Anti-rheumatic Drugs
Osteoarthritis (OA) is a degenerative joint cartilage disease characterized pathologically by osteophytes formation and subchondral bone damage. It leads to pain, stiffness, deformation and even disability in the patients, and increases the risk of comorbidities. As its pathophysiological mechanisms...
Saved in:
Main Authors: | CUI Hanshu, LIU Bin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2025-01-01
|
Series: | Xiehe Yixue Zazhi |
Subjects: | |
Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0802 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primer on the Rheumatic Diseases /
Published: (1993) -
South African Rheumatism and Arthritis Association 2024 updated guidelines for the management of rheumatoid arthritis
by: G Tarr, et al.
Published: (2024-09-01) -
Advances in the Drugs Treatment of Psoriatic Arthritis
by: LU Chaofan, et al.
Published: (2024-12-01) -
Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II
by: Zhi-Bin Wang, et al.
Published: (2025-02-01) -
End-User Experience of the 2012 WHF Echocardiographic Criteria for Diagnosis of Rheumatic Heart Disease: A Global Survey
by: Lene Thorup, et al.
Published: (2025-01-01)